Emery-Dreifuss肌营养不良1型与恶性室性心律失常及终末期心衰高风险相关
该回顾性多中心研究纳入38名男性及21名女性EMD变异携带者,中位随访65个月,发现23.7%男性发生恶性室性心律失常、13.2%发生终末期心衰,女性无上述事件;男性EMD心脏表型者的MVA和ESHF发生率与男性LMNA心脏表型者相似。
要点
- 男性EMD变异携带者需警惕恶性室性心律失常和终末期心衰风险。
- 男性EMD心脏表型者的MVA和ESHF发生率与LMNA心脏表型者相似。
- 女性EMD变异携带者未发生MVA或ESHF,但部分出现心脏表型。
核心结论
- 男性EMD变异携带者发生进行性心衰和室性心律失常的风险与男性LMNA变异携带者相似。
研究设计与样本
- 回顾性研究,从12个国际心肌病中心连续招募EMD变异携带者,随访数据含38名男性(平均年龄33.4岁)和21名女性(平均年龄43.3岁)。
主要发现
- 中位随访65.0个月,9名(23.7%)男性发生MVA,5名(13.2%)发生ESHF。
- 女性EMD变异携带者无MVA或ESHF,但9名(42.8%)在中位年龄58.6岁出现心脏表型。
临床怎么用
- 男性EMD变异携带者合并心脏病时应考虑早期植入ICD和心衰药物治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Emery-Dreifuss muscular dystrophy (EDMD) is caused by variants in EMD (EDMD1) and LMNA (EDMD2). Cardiac conduction defects and atrial arrhythmia are common to both, but LMNA variants also cause end-stage heart failure (ESHF) and malignant ventricular arrhythmia (MVA). This study aimed to better characterize the cardiac complications of EMD variants. METHODS: Consecutively referred EMD variant-carriers were retrospectively recruited from 12 international cardiomyopathy units. MVA and ESHF incidences in male and female variant-carriers were determined. Male EMD variant-carriers with a cardiac phenotype at baseline (EMDCARDIAC) were compared with consecutively recruited male LMNA variant-carriers with a cardiac phenotype at baseline (LMNACARDIAC). RESULTS: Longitudinal follow-up data were available for 38 male and 21 female EMD variant-carriers [mean (SD) ages 33.4 (13.3) and 43.3 (16.8) years, respectively]. Nine (23.7%) males developed MVA and five (13.2%) developed ESHF during a median (inter-quartile range) follow-up of 65.0 (24.3-109.5) months. No female EMD variant-carrier had MVA or ESHF, but nine (42.8%) developed a cardiac phenotype at a median (inter-quartile range) age of 58.6 (53.2-60.4) years. Incidence rates for MVA were similar for EMDCARDIAC and LMNACARDIAC (4.8 and 6.6 per 100 person-years, respectively; log-rank P = .49). Incidence rates for ESHF were 2.4 and 5.9 per 100 person-years for EMDCARDIAC and LMNACARDIAC, respectively (log-rank P = .09). CONCLUSIONS: Male EMD variant-carriers have a risk of progressive heart failure and ventricular arrhythmias similar to that of male LMNA variant-carriers. Early implantable cardioverter defibrillator implantation and heart failure drug therapy should be considered in male EMD variant-carriers with cardiac disease.
引用
- Cannie DE, Syrris P, Protonotarios A, et al. Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure. Eur Heart J. 2023. PMID: 37639473. doi:10.1093/eurheartj/ehad561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。